In addition, substantial progress has been made in our understanding of individual ISGs (ISG15, IFIT2, IFITM3) in CNS viral infection and diseases in recent years (Table 1), providing an essential target for the development of novel antivirals and anti-neurological disease drugs. This evidence concerns the gene IFIT2 and nervous system disorder.